Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-18-000310
Filing Date
2018-03-23
Accepted
2018-03-22 18:47:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #4 s24221487.htm SC 13D/A 22717
2 SECOND WARRANT AMENDMENT AGREEMENT s24221487b.htm EX-5.1 38893
  Complete submission text file 0000899140-18-000310.txt   63187
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Subject) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53409 | Film No.: 18707976
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

EIN.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A